1. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer
   Ping Yang et al, 2020, Current Medicinal Chemistry CrossRef
2. Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma
   Damla Isci et al, 2021, Cancers CrossRef
3. MKP1 phosphatase is recruited by CXCL12 in glioblastoma cells and plays a role in DNA strand breaks repair
   Matthias Dedobbeleer et al, 2020, Carcinogenesis CrossRef
4. N-terminal polypeptide derived from vMIP-II exerts its antitumor activity by inhibiting the CXCR4 pathway in human glioma
   Qingling Yang et al, 2017, International Journal of Oncology CrossRef
5. Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?
   Vasileios Arzoglou et al, 2018, British Journal of Neurosurgery CrossRef
6. At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer
   Gary D Luker et al, 2021, Journal of Leukocyte Biology CrossRef
7. Upregulation of musashi1 increases malignancy of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway and predicts a poor prognosis
   Qiuhua Liu et al, 2019, BMC Gastroenterology CrossRef
8. The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway
   Ana Virginia Sánchez-Sánchez et al, 2021, International Journal of Molecular Sciences CrossRef
9. Overcoming multidrug resistance by reversan and exterminating glioblastoma and glioblastoma stem cells by delivering drug-loaded nanostructure hybrid lipid capsules (nHLCs)
   Uzma Hasan et al, 2024, Drug Delivery and Translational Research CrossRef
10. Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas
    Vivian Adamski et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
11. NKG2D ligands in glioma stem-like cells: expression in situ and in vitro
    Charlotte Flüh et al, 2018, Histochemistry and Cell Biology CrossRef
12. The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma
    Giovanni Luca Gravina et al, 2017, Journal of Hematology & Oncology CrossRef